The FDA sent a letter to the manufacturers of 10 popular antidepressants asking them to beef up their labels to highlight possible serious side effects, including suicide. The FDA also urged doctors and parents to pay close attention to those taking the drugs, especially children. While the FDA said experts have not been able to state with certainty that it is use of the drugs, and not the condition itself, that causes behavioral changes, the administration said increased off-label use of the drugs by non-psychiatrists makes it important that the warnings be better known. Several drug makers said they were studying the request and would decide soon on how to react.

Related Summaries